Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: exemestane|DRUG: sunitinib malate|OTHER: placebo
Sponsor: Institut Català d'Oncologia